CVPath Institute Inc

Come read our latest article reviewing the spectrum of macrophage phenotypes and how they contribute to atherosclerotic plaque development and progression. pubmed.ncbi.nlm.nih.gov/35942866/

Our new publication aimed to quantify the frequency of embolic debris captured by the SENTINEL-CPS in lower-risk TAVR cases. pubmed.ncbi.nlm.nih.gov/35272475/

@CVPath_Md celebrates Histotechnology Professionals Day March 10, 2022

Read our review article for a deeper understanding of sex differences and the risk factors of coronary atherosclerosis that may lead to improved outcomes of CVD in women. Sex Differences in Coronary Atherosclerosis pubmed.ncbi.nlm.nih.gov/35175547/

Our new publication highlighting the importance of cytokine storm-related hypercoagulation in the pathogenesis of stent thrombosis in patients with SARS-CoV-2: Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity pubmed.ncbi.nlm.nih.gov/33863660/

Dr Kenji Kawai presents at #CRT2022 “Use of the Pulse NanoMed System to Facilitate Chronic Total Occlusion Recanalization and Reconstitution in Cadaver Limbs”

Dr Kenji Kawai (CVPath Fellow) presented at #CRT2022 “Acute Stent Thrombogenicity In The Transition From DAPT To SAPT In An Ex Vivo Pig Blood Flow Loop System” which was awarded best abstract

CVPath’s presence was prominent at #CRT2022. Dr Aloke Finn, Medical Director, presented a plethora of talks.

Check out the recently published article, a study led by Dr. Anne Cornelissen, in Future Cardiology, indicating the significance of COBRA PzF nanocoated coronary stents. futuremedicine.com/doi/10.2217/fc…

Congratulations to CVPath's Founder and President Dr. Renu Virmani who has been awarded the 11th TCTAP Award “Master of the Masters”! summit-tctap.com/2021/program_a…

CVPath used an AWS-powered platform for the data in our research on cardiac injury in COVID-19 patients, discussed in more detail on the AWS Public Sector Blog. Learn more about the platform's role in our research and the conclusions that followed: aws.amazon.com/blogs/publicse…

Featured in @JACCJournals is a recent study led by Yu Sato and Sho Torii on calcified nodules as a cause of coronary thrombosis. The full article can be found here: sciencedirect.com/science/articl…

@Medscape has a new review of CVPath's recent JACC publication on myocarditis as a result of #COVID19: medscape.com/viewarticle/94…

Additional coverage from @TCTMD following last week's publication looking at the link between myocarditis and #COVID19: tctmd.com/news/microvasc…

great summary by @lamckeown1 @TCTMD of our recent JACC review on pathological evidence for COVID-19 induced myocarditis @CVPath_Md

Review Shows Little Risk for Myocarditis in COVID-19 medscape.com/viewarticle/94… via @medscape @JACCJournals

JACC Review Topic of the Week: “Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis” from CVPath’s Rika Kawakami, MD, and Atsushi Sakamoto, MD. sciencedirect.com/science/articl…

Congratulations to Dr. Renu Virmani from CVPath Institute, who has recently been noted as one of the Clarivate 2020 Highly Cited Researchers for publications ranking in the top 1% by citations for field and year. #HighlyCited2020 recognition.webofscience.com/awards/highly-…

New publication from lead authors, and former CVPath fellows, Hiroyuki Jinnouchi and Fumiyuki Otsuka: “Healthy Strut Coverage After Coronary Stent Implantation: An Ex Vivo Human Autopsy Study.” ahajournals.org/doi/10.1161/CI…

If you missed TCT Connect 2020, here's a review on CVPath’s recently published paper from @AlokeFinn and research fellow Yu Sato. During Sunday's session, Yu presented findings on the significance of treating accessory arteries in renal denervation: tctmd.com/news/treating-…